🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The use of C1INH (Berinert) in patients receiving deceased donor kidney tra...
Status
Completed
Location
Cedars-Sinai Medical Center
Start Date
2014-09
Trial ID
NCT02134314
Treatments Being Tested
This is a phase 3, open-label study to evaluate the safety of pegcetacoplan...
Status
Completed
Location
California Retina Consultants
Start Date
2025-10-24
Trial ID
NCT07214740
Treatments Being Tested
The objectives of the study are to assess the safety, tolerability, prelimi...
Status
Completed
Location
Prince of Wales Hospital
Start Date
2015-12-01
Trial ID
NCT02588833
Treatments Being Tested
The primary objective of this study will be to evaluate the pharmacokinetic...
Status
Completed
Location
Clinical Pharmacology of Miami, Inc.
Start Date
2018-04-17
Trial ID
NCT06004934
Treatments Being Tested
Coversin in Paroxysmal Nocturnal Haemoglobinuria (PNH) in patients with res...
Status
Completed
Location
Dr Saskia Langemeijer
Start Date
2016-02
Trial ID
NCT02591862
Treatments Being Tested
First-In-Human Study To Evaluate The Safety, Tolerability, Pharmacokinetics...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2023-09-28
Trial ID
NCT05937581
This was a 2-part study (Part 1 and Part 2), with each part being an open-l...
Status
Completed
Location
Clinical Study Site
Start Date
2019-12-22
Trial ID
NCT04709081
Treatments Being Tested
The ImmuneNet study is a Phase I/II clinical trial sponsored by Truway Heal...
Status
Enrolling By Invitation
Location
Truway Health, Inc. www.truwayhealth.com (401 E 34th Street, S11P, New York, NY 10016)
Start Date
2025-10-23
Trial ID
NCT07221565
The primary purpose of this study was to assess the noninferiority of ravul...
Status
Completed
Location
Research Site
Start Date
2016-12-12
Trial ID
NCT02946463
Treatments Being Tested
The purpose of the study is to assess the safety and efficacy of ravulizuma...
Status
Completed
Location
Clinical Trial Site
Start Date
2017-01-11
Trial ID
NCT02949128
Treatments Being Tested